FDA approves RSV vaccine for moms-to-be to guard their newborns
by LAURAN NEERGAARD AP Medical Writer
This image provided by Pfizer shows the RSV vaccine. U.S. regulators on Monday, Aug. 21, 2023, approved the first RSV vaccine for pregnant women so their babies will be born with protection against the scary respiratory infection. (Pfizer via AP)